ÀLex Bofi i Cuadros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
ÀLex Bofi i Cuadros has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ali Hashemi Gheinani
Functional Urology Research Group, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland
1 shared publicationCaroline Krüger
Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
1 shared publication- Chiara Laura
Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
1 shared publication - Daniela Claudino Carvoeiro
Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland
1 shared publication - Jens Volker Stein
Department of Oncology, Microbiology, and Immunology, University of Fribourg, Fribourg, Switzerland
1 shared publication - Jianwen Zhou
Department of Biology, University of Fribourg
1 shared publication
Latest Publications
- 30 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6797) , eadq2080
Lymphoid tissue chemokines limit priming duration to preserve CD8 + T cell functionality
The generation of effector CD8 + T cells (T EFF ) requires activation of naïve CCR7 + T cells (T N ) by dendritic cells (DCs) in lymphoid tissue. How T N -DC interaction duration and signal integration are controlled remains unclear. In this study, we show that lymphoid stroma–secreted CCR7 ligands limit interaction duration by progressively inducing CD8 + T cell release from DCs. At late interaction stages, CCR7 ligands relocalize the F-actin regulator DOCK2 away from the DC interface, permitting T cell detachment, proliferation onset, and acquisition of cytotoxicity. Disruption of CCR7 signaling causes prolonged T cell–DC contacts and produces dysfunctional T EFF with elevated inhibitory receptors, reduced antimicrobial activity, and impaired recall responses. Stromal chemokines therefore act as critical regulators of T cell priming by DCs, preserving CD8 + effector function during acute and memory phases.
- 30 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6797) , eadq2080
Lymphoid tissue chemokines limit priming duration to preserve CD8 + T cell functionality
The generation of effector CD8 + T cells (T EFF ) requires activation of naïve CCR7 + T cells (T N ) by dendritic cells (DCs) in lymphoid tissue. How T N -DC interaction duration and signal integration are controlled remains unclear. In this study, we show that lymphoid stroma–secreted CCR7 ligands limit interaction duration by progressively inducing CD8 + T cell release from DCs. At late interaction stages, CCR7 ligands relocalize the F-actin regulator DOCK2 away from the DC interface, permitting T cell detachment, proliferation onset, and acquisition of cytotoxicity. Disruption of CCR7 signaling causes prolonged T cell–DC contacts and produces dysfunctional T EFF with elevated inhibitory receptors, reduced antimicrobial activity, and impaired recall responses. Stromal chemokines therefore act as critical regulators of T cell priming by DCs, preserving CD8 + effector function during acute and memory phases.